Tests a new robotic surgery for esophageal cancer patients
Tests a new robotic surgery approach to remove the esophagus in adults with esophageal cancer.
Key facts
- Who runs it
- Centre hospitalier de l'Université de Montréal (CHUM)
- Where
- Montreal, CanadaSee the site
- Trial code
- Registry title
- Outside the Cage (OTC) Robotic Esophagectomy
- Status
- Not yet recruiting
- Phase
- Phase 1
- People taking part
- 31 people, planned
- Starts
- 1 Jan 2027
- Expected to end
- 1 Jan 2028
- Type of study
- Interventional
- Treatments tested
- OTC MIE Esophagectomy
- Record updated
- 18 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with stage I, II or III esophageal cancer who are scheduled for keyhole (minimally invasive) surgery to remove the esophagus at the CHUM.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Clinical stage I, II or III esophageal cancer (cT1-3N0-2M0)
- Earlier treatment
- Must be scheduled to have minimally invasive esophagectomy (MIE) by VATS/RATS at the CHUM
Main reasons for not taking part
- Younger than 18 years
- Unable to consent to the study
- Pregnancy
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- All patients with clinical stage I, II, or III esophageal cancer (cT1-3N0-2M0) scheduled to undergo minimally invasive esophagectomy (MIE) by VATS/RATS at the CHUM
Who cannot take part
- Age < 18 years old
- Inability to consent to the study
- Pregnancy
Where in Canada
- CHUMMontreal, CanadaContact: Moishe Liberman, MD, PhDNo longer taking part
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate the feasibility and safety of a novel non-intercostal robotic approach for minimally invasive esophagectomy (OTC MIE) in the treatment of esophageal cancer. This study aims to determine whether OTC MIE reduces the risk of acute and chronic chest pain compared to traditional minimally invasive esophagectomy (MIE) and improves postoperative outcomes for patients. Participants will undergo either the OTC MIE procedure or a traditional MIE approach as part of their treatment for esophageal cancer. Postoperative outcomes, including chest pain and recovery metrics, will be closely monitored. Follow-up assessments will be conducted to evaluate the long-term safety and effectiveness of the novel approach. The investigators aim to recruit 31 patients.
The group in the trial
- Out of the Cage Minimally Invasive Esophagectomy (OTC MIE)Treatment being tested
Consented patients will undergo minimally invasive esophagectomy (MIE) using the Out of the Cage (OTC) robotic approach. This approach follows the standard procedural steps typically used in minimally invasive esophagectomy (e.g., laparoscopy and robotic-assisted thoracic surgery), with the primary difference being the incisions. Instead of intercostal incisions, the thoracic component of the procedure will be performed using 1 to 4 subcostal ports, tailored to the patient's anatomy and the case requirements.
Treatment: OTC MIE Esophagectomy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Outside the Cage (OTC) Robotic Esophagectomy , Single Center Phase I Trial
- Plain-language title
- Tests a new robotic surgery for esophageal cancer patientsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 18 March 2026